PHYSIOVITH
ActiveSummary
PHYSIOVITH has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €406,918 and a net result of €109,611. Equity is growing by ~35.2% per year across the filed fiscal years. Its solvency ranks better than 38% of 777 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Highest result since 2021net €109,611 ▲58.8%
Operating result €143,905, net result €109,611, both a record.
02-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Liquidity doublescurrent ratio 12.69
Current ratio from 5.95 to 12.69; short-term debt falls from €93,991 to €49,512.
25-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Weakest financial yearnet €54,957 ▼10.7%
Net result drops to €54,957, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €200,000Eq €228,289 ▲31.7%
3 profitable years in a row build equity to €228,289.
27-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Equity above €150,000Eq €173,331 ▲55.1%
2 profitable years in a row build equity to €173,331.
17-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.